Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis

Currently, special attention is paid to timely treatment for active forms of multiple sclerosis (MS), especially for highly active MS (HAMS), in which there are ≥2 exacerbations and corresponding activity signs that are detected by magnetic resonance imaging (MRI) regardless of previous therapy with...

Description complète

Détails bibliographiques

Auteurs principaux:	K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina
Format:	Artigo
Langue:	Russo
Publié:	IMA-PRESS LLC 2020-06-01
Collection:	Неврология, нейропсихиатрия, психосоматика
Sujets:	highly active multiple sclerosis immunoreconstitution therapy cladribine tablets pregnancy and childbirth in multiple sclerosis
Accès en ligne:	https://nnp.ima-press.net/nnp/article/view/1359
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!